Artificial sight used for the first time in Europe

Article

A blind person's sight has been restored by surgeons at the University Hospitals of Geneva (HUG) for the first time in Europe using American technology.

A blind person's sight was restored by surgeons at the University Hospitals of Geneva (HUG) for the first time in Europe using American technology.

Believed to be only the tenth procedure of its kind performed in the world, the technology was developed by Second Sight, a California-based company in the US.

A tiny camera and transmitter are mounted in eyeglasses and an implanted receiver and a device containing 60 electrodes is secured to the retina with a wire the width of a human hair.

"This kind of implant is suitable for people who suffer from a well-defined malady, retinitis pigmentosa," said Avinoam Safran, chief doctor at HUG's Ophthalmology Department. The technology is not expected to restore vision completely to the patient, he noted.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.